Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus dexmedetomidine for inflammatory response in laparoscopic hysterectomy
PACTR201910617459894Phase 3Recruiting
- Sponsor
- Lamees Mohamed Dawood
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ketamine and dexmedetomidine in Perioperative inflammation (PI) (3 arms), sponsored by Lamees Mohamed Dawood. Primary endpoints: Tumor necrosis factor-alpha, Interleukin 6 and 1 more. Started Nov 2019; status: recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
Perioperative inflammation (PI)
Beyond the preview
Go deeper on PACTR201910617459894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201910617459894.